News, Stories, Photos about Asia Human Rights, Culture, Poltics, Economy

FDA reviews diabetic and HIV medications


Published: March 27, 2008 at 2:09 PM
Print story
Email to a friend
Font size:
WASHINGTON, March 27 (UPI) -- The U.S. Food and Drug Administration has announced safety reviews of the FDA-approved medications Regranex Gel, Ziagen and Videx.

The FDA said study data suggests there might be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel to treat leg and foot ulcers.

The FDA said it was also studying data that indicate a higher risk of heart attack in patients infected with the human immunodeficiency virus who take Ziagen (abacavir) or Videx (didanosine) as part of their drug therapy.

Until all three reviews are completed, the FDA said health care professionals should evaluate the potential risks and benefits of each drug with their patients.

© 2008 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.
Print story
Order reprints
Email to a friend
Post comment
See Also:
» Next in Science: Scientists test new prostate disease drug

TRANSONIC WIND TUNNEL
Grady McCoy stands in the Langley Research Center's 16 foot transonic tunnel, as light reflects off the fan blades in this image from 1990 in Hampton, Virginia. As part of a national initiative to optimize government-owned wind tunnels, NASA's Langley Research Center shut down the tunnel and transitioned work to other facilities. During its operational lifetime, the tunnel supported development of all fighters since the 1960s, such as the F-14, F-15, F-18 and the Joint Strike Fighter. (UPI Photo/NASA)
NASA's Transonic wind tunnel at Langley Research Center
Full Photo | Slideshow